234 related articles for article (PubMed ID: 11787477)
1. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
O'Shaughnessy KM; Fu B; Dickerson C; Thurston D; Brown MJ
Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
[TBL] [Abstract][Full Text] [Related]
2. Modifying effects of the R389G beta1-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea.
Börgel J; Schulz T; Bartels NK; Epplen JT; Büchner N; Rump LC; Huesing A; Sanner BM; Mügge A
Clin Sci (Lond); 2006 Jan; 110(1):117-23. PubMed ID: 16122377
[TBL] [Abstract][Full Text] [Related]
3. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
4. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
Johnson JA; Zineh I; Puckett BJ; McGorray SP; Yarandi HN; Pauly DF
Clin Pharmacol Ther; 2003 Jul; 74(1):44-52. PubMed ID: 12844134
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
Zateyshchikov DA; Minushkina LO; Brovkin AN; Savel'eva EG; Zateyshchikova AA; Manchaeva BB; Nikitin AG; Sidorenko BA; Nosikov VV
Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
[TBL] [Abstract][Full Text] [Related]
6. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
7. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
8. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
[TBL] [Abstract][Full Text] [Related]
9. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
10. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
Snapir A; Koskenvuo J; Toikka J; Orho-Melander M; Hinkka S; Saraste M; Hartiala J; Scheinin M
Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
[TBL] [Abstract][Full Text] [Related]
11. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
12. Job strain, job demands and adrenergic beta1-receptor-polymorphism: a possible interaction affecting blood pressure in men.
Ohlin B; Berglund G; Nilsson PM; Melander O
J Hypertens; 2008 Aug; 26(8):1583-9. PubMed ID: 18622236
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
14. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.
Corea L; Valori C; Bentivoglio M; Verdecchia P; Bichisao E
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):554-9. PubMed ID: 2866164
[TBL] [Abstract][Full Text] [Related]
15. Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects.
Gjesing AP; Andersen G; Albrechtsen A; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
Diabet Med; 2007 Apr; 24(4):392-7. PubMed ID: 17335470
[TBL] [Abstract][Full Text] [Related]
16. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives.
Westhoff TH; Franke N; Schmidt S; Vallbracht-Israng K; Zidek W; Dimeo F; van der Giet M
J Hum Hypertens; 2007 Jun; 21(6):486-93. PubMed ID: 17330056
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
Hirota K; Baba S; Fukushi S; Muraoka M; Matsuki A
J Anesth; 2005; 19(1):17-20. PubMed ID: 15674510
[TBL] [Abstract][Full Text] [Related]
19. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
20. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
